User profiles for W. Timens

Wim Timens

University of Groningen, University Medical Center Groningen
Verified email at umcg.nl
Cited by 43689

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)

AR Bourgonje, AE Abdulle, W Timens… - The Journal of …, 2020 - Wiley Online Library
Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional host
receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

The pathology of chronic obstructive pulmonary disease

JC Hogg, W Timens - Annual Review of Pathology: Mechanisms …, 2009 - annualreviews.org
The pathogenesis of chronic obstructive pulmonary disease (COPD) is based on the innate
and adaptive inflammatory immune response to the inhalation of toxic particles and gases. …

Acute effects of cigarette smoke on inflammation and oxidative stress: a review

H van der Vaart, DS Postma, W Timens… - Thorax, 2004 - thorax.bmj.com
Compared with the effects of chronic smoke exposure on lung function and airway inflammation,
there are few data on the acute effects of smoking. A review of the literature identified …

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

I Hamming, W Timens, MLC Bulthuis… - The Journal of …, 2004 - Wiley Online Library
Severe acute respiratory syndrome (SARS) is an acute infectious disease that spreads mainly
via the respiratory route. A distinct coronavirus (SARS‐CoV) has been identified as the …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, LA Muscarella, VM Fazio, H Groen, W Timens… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

…, J Sänger, J Clement, H Groen, W Timens… - Science translational …, 2010 - science.org
Lung cancer remains one of the leading causes of cancer-related death in developed countries.
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …

[HTML][HTML] An integrated cell atlas of the lung in health and disease

…, D Sheppard, DP Shepherd, DD Sin, W Timens… - Nature Medicine, 2023 - nature.com
Single-cell technologies have transformed our understanding of human tissues. Yet, studies
typically capture only a limited number of donors and disagree on cell type definitions. …

[HTML][HTML] Management of lung nodules detected by volume CT scanning

…, W Timens, D Willebrand, A Vink, W Mali… - … England Journal of …, 2009 - Mass Medical Soc
Background The use of multidetector computed tomography (CT) in lung-cancer screening
trials involving subjects with an increased risk of lung cancer has highlighted the problem for …

Ongoing airway inflammation in patients with COPD who do not currently smoke

…, HF Kauffman, TW van der Mark, GH Koëter, W Timens - Thorax, 2000 - thorax.bmj.com
BACKGROUND Inflammatory changes in the airways in chronic obstructive pulmonary disease
(COPD) are largely attributed to smoking, yet they may be present even if patients do not …

Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

…, I Petersen, JH Clement, H Groen, W Timens… - Cancer discovery, 2011 - AACR
Although genomically targeted therapies have improved outcomes for patients with lung
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…